-- DAYBUE and DAYBUE STIX are the only FDA-approved treatments for Rett syndrome, a rare neurodevelopmental disorder “DAYBUE, the first and only approved treatment for Rett syndrome, has provided ...
COMMACK, NY, Dec. 10, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced ...
AUSTIN, Texas, Oct. 31, 2025 /PRNewswire/ -- Otsuka ICU Medical LLC is issuing a voluntary recall to the user level, for a MISLABELED lot of POTASSIUM CHLORIDE Inj. 20 mEq, NDC 0990-7077-14. The ...
Methotrexate is a globally recognized therapy in oncology and autoimmune disorders. Traditionally available as tablets or injections, it often poses challenges in dosing and administration—especially ...
Hypokalemia and even low-normal plasma potassium levels increase the risk of ventricular arrhythmias among patients with cardiovascular disease. An assessment of a strategy of actively increasing ...
You need potassium to support just about every bodily function, including a beating heart. It is readily available in many foods, but there are a few situations in which your doctor may recommend a ...
DUBLIN, June 9, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced late-breaking Phase 4 data evaluating treatment benefits of Xywav ® (calcium, magnesium, potassium, and ...
First presentation of the Phase 4 XYLO switch study reports blood pressure reductions in patients with narcolepsy when switching from twice-nightly high- to low-sodium oxybate Novel intermediate ...
Potassium nitrate (KNO 3), known historically as saltpeter or the mineral niter, is a common salt with multiple uses. It has been known since antiquity; an early appearance in the chemical literature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results